We are live on ! Find out more
PROK icon

ProKidney
PROK

18 hedge funds and large institutions have $144M invested in ProKidney in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

23% less capital invested

Capital invested by funds: $187M → $144M (-$42.5M)

48.87% less ownership

Funds ownership: 74.91% → 26.04% (-49%)

73% less funds holding

Funds holding: 67 → 18 (-49)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 60

Holders
18
Holders Change
-49
Holders Change %
-73.13%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
1
Reduced
4
Closed
60
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$90.1M
2
SCM
Suvretta Capital Management
New York
+$27.8M
3
BL
Bleichroeder LP
New York
+$17.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.32M
5
BlackRock
BlackRock
New York
+$947K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$17.4M
2
Millennium Management
Millennium Management
New York
-$14.8M
3
ACA
Arena Capital Advisors
California
-$11.7M
4
SC
Sculptor Capital
New York
-$11.1M
5
FTCM
First Trust Capital Management
Illinois
-$8.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
– -$6.2M -623,545 Closed
GL
27
Governors Lane
New York
– -$5.97M -600,000 Closed
6CM
28
683 Capital Management
New York
– -$4.97M -500,000 Closed
ECP
29
Empyrean Capital Partners
California
– -$4.97M -500,000 Closed
WC
30
Wealthspring Capital
New York
– -$4.64M -466,376 Closed
HSBC Holdings
31
HSBC Holdings
United Kingdom
– -$4.36M -445,142 Closed
MF
32
Magnetar Financial
Illinois
– -$4.32K -434,388 Closed
Bank of America
33
Bank of America
North Carolina
– -$3.68M -423,290 -100%
Alyeska Investment Group
34
Alyeska Investment Group
Illinois
– -$4.19M -420,837 Closed
HI
35
HBK Investments
Texas
– -$4M -400,000 Closed
UOC
36
UBS O'Connor
Illinois
– -$3.61M -362,372 Closed
PC
37
Periscope Capital
Ontario, Canada
– -$3.6M -359,781 Closed
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
– -$3.05M -306,764 Closed
Calamos Advisors
39
Calamos Advisors
Illinois
– -$2.98M -300,000 Closed
MCP
40
Maso Capital Partners
Hong Kong
– -$2.98M -300,000 Closed
TAL
41
TIG Advisors LLC
New York
– -$2.87M -287,935 Closed
SIA
42
Schechter Investment Advisors
Michigan
– -$2.85M -285,950 Closed
MA
43
MYDA Advisors
New York
– -$2.31M -232,000 Closed
SCM
44
Saba Capital Management
New York
– -$2.14M -215,476 Closed
APM
45
Avidity Partners Management
Texas
– -$1.99M -200,000 Closed
IPCP
46
Iron Park Capital Partners
New York
– -$2M -200,000 Closed
AA
47
AQR Arbitrage
Connecticut
– -$1.9M -191,100 Closed
VI
48
Vestcor Inc
New Brunswick, Canada
– -$1.74M -175,000 Closed
HF
49
HRT Financial
New York
– -$1.55M -156,274 Closed
BI
50
Bulldog Investors
New Jersey
– -$1.53M -153,378 Closed
1
2
3 4

PROK Hedge Fund Activity: Q3 2022 in Review

18 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q3 2022, worth a combined $144M — down 23% from $187M a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of PROK and 12 opened new positions — a net loss of 48 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $90.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $17.4M sold.

  • 18 institutional investors held ProKidney (PROK) as of Q3 2022, down from 67 in Q2 2022.
  • Funds reported $144M of ProKidney stock for Q3 2022, down 23% quarter-over-quarter.
  • 12 funds opened new ProKidney positions in Q3 2022 and 60 closed out, a net change of -48 holders.
  • The largest ProKidney buyer in Q3 2022 was Morgan Stanley, an estimated $90.1M added.
  • The largest ProKidney seller in Q3 2022 was Adage Capital Partners, an estimated $17.4M sold.

Based on aggregated 13F filings for Q3 2022.